• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.

作者信息

Cobbe S M, Manley B S

出版信息

Cardiovasc Res. 1985 Feb;19(2):69-75. doi: 10.1093/cvr/19.2.69.

DOI:10.1093/cvr/19.2.69
PMID:3978667
Abstract

The electrophysiological and mechanical effects of sotalol, a beta-adrenergic blocker with Class III antiarrhythmic properties, were compared with those of atenolol in rabbit right ventricular papillary muscles studied in vitro using intracellular microelectrodes. Sotalol produced a dose-dependent increase in action potential duration and effective refractory period without any effect on parameters of rapid inward current. Atenolol had no Class I or Class III effect. The actions of equipotent beta-blocking concentrations of sotalol (10(-4) mol X litre-1) and of atenolol (10(-5) mol X litre-1) in elevated extracellular potassium concentrations of 8 and 12 mmol X litre-1 were investigated. There were reductions in membrane potential, action potential amplitude and upstroke velocity in elevated potassium which were not influenced by sotalol and atenolol, apart from a small additional depression of action potential amplitude and membrane potential in 12 mmol X litre-1 potassium. Hyperkalaemia caused shortening in action potential duration but lengthening in effective refractory period (post-repolarisation refractoriness). The increase in effective refractory period over control produced by sotalol in normal potassium was preserved in elevated potassium. This effect was attributable to lengthening of action potential duration rather than alteration in the duration of post-repolarisation refractoriness. The Class III effects of sotalol are preserved even in partially depolarised fibres where rapid inward current is depressed.

摘要

相似文献

1
Effects of elevated extracellular potassium concentrations on the class III antiarrhythmic action of sotalol.
Cardiovasc Res. 1985 Feb;19(2):69-75. doi: 10.1093/cvr/19.2.69.
2
Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol.盐酸索他洛尔和右旋索他洛尔对心肌缺血期间细胞外钾离子浓度升高的抑制作用
Cardiovasc Res. 1990 May;24(5):404-10. doi: 10.1093/cvr/24.5.404.
3
Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
Cardiovasc Res. 1986 Oct;20(10):705-9. doi: 10.1093/cvr/20.10.705.
4
Interaction of the effects of hypoxia, substrate depletion, acidosis and hyperkalaemia on the class III antiarrhythmic properties of sotalol.
Cardiovasc Res. 1985 Nov;19(11):668-73. doi: 10.1093/cvr/19.11.668.
5
Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.Ⅲ类药物d-索他洛尔和多非利特对豚鼠乳头肌的差异速率及钾依赖性效应
Cardiovasc Drugs Ther. 1998 Dec;12(6):573-83. doi: 10.1023/a:1007743521932.
6
Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.新型III类抗心律失常药物MS-551对兔心室肌细胞动作电位和膜电流的影响。
Br J Pharmacol. 1993 May;109(1):157-63. doi: 10.1111/j.1476-5381.1993.tb13546.x.
7
The influence of acute myocardial ischaemia on the class III antiarrhythmic action of sotalol.
Cardiovasc Res. 1985 Nov;19(11):661-7. doi: 10.1093/cvr/19.11.661.
8
Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.在常氧及缺氧/缺血条件下,Ⅲ类药物与格列本脲对豚鼠乳头肌动作电位时程的不同影响。
Br J Pharmacol. 1993 Oct;110(2):531-8. doi: 10.1111/j.1476-5381.1993.tb13843.x.
9
Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.新型III类抗心律失常药物EGIS-7229(S 21407)对体内外心肌电刺激不应期的影响。
J Cardiovasc Pharmacol. 2001 Jan;37(1):78-88. doi: 10.1097/00005344-200101000-00009.
10
Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.新型N-(苯氧基烷基)-N-苯基烷基胺GYKI-16638对家兔的抗心律失常和电生理作用
Eur J Pharmacol. 2000 Sep 15;404(1-2):181-90. doi: 10.1016/s0014-2999(00)00591-4.

引用本文的文献

1
Repolarisation and refractoriness during early ischaemia in humans.人类早期缺血期间的复极化和不应期
Heart. 2000 Oct;84(4):365-9. doi: 10.1136/heart.84.4.365.
2
Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.索他洛尔。对其药效学和药代动力学特性以及治疗用途的综述。
Drugs. 1987 Sep;34(3):311-49. doi: 10.2165/00003495-198734030-00002.
3
Electrophysiological effects of melperone on isolated rabbit heart muscles.美哌隆对离体兔心肌的电生理效应。
Br J Pharmacol. 1988 Aug;94(4):1063-8. doi: 10.1111/j.1476-5381.1988.tb11623.x.
4
Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle.
Cardiovasc Drugs Ther. 1992 Aug;6(4):429-36. doi: 10.1007/BF00054193.